Literature DB >> 30088025

[Strategies for digitalizing the hospital of the future].

W Deiters1, A Burmann2, S Meister2.   

Abstract

Digitalization cannot be understood as an off-the-shelf product, bought as a one-time purchase in a warehouse. It rather requires a constantly developing vision, which comes with a continuous transformation process, hand in hand with strategic innovation management. Thus, digitalization means understanding the digital maturity level of an enterprise and the digital skills of the employees. Besides an investment in products, a successful digitalization process also necessitates consideration of the cost to release employees from their obligations in order to contribute to the process as well as for a dedicated and continuing staff training and education program. While digitalization in Germany is underdeveloped regarding both the national health infrastructure and the level of digitalization in hospitals, German clinics are recognizing more and more the importance of digitalization and are initiating digitalization strategies. In this regard, we can learn from our European partners, who have partially established advanced and innovative solutions. Looking into these flagship projects can help to see potentials and to identify valuable building blocks for our own strategy.

Keywords:  Clinical logistics; Health communication; Health information exchange; Patient data; Training

Mesh:

Year:  2018        PMID: 30088025     DOI: 10.1007/s00120-018-0731-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  2 in total

1.  Understanding EMRAM and how it can be used by policy-makers, hospital CIOs and their IT teams.

Authors:  Lorren Pettit
Journal:  World Hosp Health Serv       Date:  2013

Review 2.  [Development of telemedical solutions based on the electronic case record (EFA)].

Authors:  W Deiters; S Houta
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2015-10       Impact factor: 1.513

  2 in total
  1 in total

Review 1.  Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.

Authors:  Erik Tambuyzer; Benjamin Vandendriessche; Christopher P Austin; Philip J Brooks; Kristina Larsson; Katherine I Miller Needleman; James Valentine; Kay Davies; Stephen C Groft; Robert Preti; Tudor I Oprea; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2019-12-13       Impact factor: 84.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.